Opendata, web and dolomites

PD_Pal SIGNED

Palliative care in Parkinson’s disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PD_Pal project word cloud

Explore the words cloud of the PD_Pal project. It provides you a very rough idea of what is the project "PD_Pal" about.

ones    ambition    academy    considerable    complications    albeit    layer    added    graduate    marked    post    quality    limits    daily    groups    involvement    multidisciplinary    society    positioned    interdisciplinary    stages    association    planning    outpatient    national    caregiver    causing    translate    psychosocial    physical    team    neurology    clinicians    treating    countries    model    palliative    roles    pal    randomised    satisfaction    experts    transfer    care    longer    course    poor    mobility    independence    associations    services    living    guidelines    spiritual    disorders    autonomy    unmet    intervention    curriculum    online    people    progressive    loved    societies    parkinson    massive    medical    cancer    symptom    validate    stage    effectiveness    pd    active    disease    neurodegenerative    specialized    economic    mooc    disorder    movement    motor    international    lay    continuity    disability    patients    sustainability    easily    feasibility    trial    family    prove    mounting    life    distress   

Project "PD_Pal" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITA DEGLI STUDI DI PADOVA 

Organization address
address: VIA 8 FEBBRAIO 2
city: PADOVA
postcode: 35122
website: www.unipd.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 3˙995˙437 €
 EC max contribution 3˙995˙437 € (100%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SC1-2018-Single-Stage-RTD
 Funding Scheme RIA
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2022-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITA DEGLI STUDI DI PADOVA IT (PADOVA) coordinator 600˙000.00
2    STICHTING KATHOLIEKE UNIVERSITEIT NL (NIJMEGEN) participant 597˙500.00
3    PARACELSUS MEDIZINISCHE PRIVATUNIVERSITAT SALZBURG - PRIVATSTIFTUNG AT (SALZBURG) participant 450˙000.00
4    UNIVERSITY COLLEGE LONDON UK (LONDON) participant 435˙000.00
5    PANEPISTIMIO IOANNINON EL (IOANNINA) participant 378˙250.00
6    EESTI LIIGUTUSHAIRETE SELTS EE (TARTU) participant 362˙500.00
7    MEDIOLANUM CARDIO RESEARCH SRL IT (MILANO) participant 322˙500.00
8    KING'S COLLEGE LONDON UK (LONDON) participant 318˙750.00
9    PHILIPPS UNIVERSITAET MARBURG DE (MARBURG) participant 293˙437.00
10    PD NEUROTECHNOLOGY LTD UK (LONDON) participant 237˙500.00

Map

 Project objective

Parkinson’s Disease (PD) is the second most common neurodegenerative disorder and is characterized in its advanced stages by motor and non-motor complications causing progressive loss of autonomy in activities of daily living, poor quality of life, marked caregiver distress, and high utilization of medical services. Similar to cancer patients, albeit for much longer duration, PD patients have considerable (and mounting) unmet physical, psychosocial and spiritual needs, and experience great problems with continuity of care. The overall ambition of PD_Pal is to validate a new model of palliative care which would be easily integrated with traditional management when disability limits mobility and independence. PD_Pal will provide an added layer of support to patients, their loved ones, and treating clinicians. PD_Pal randomised controlled trial will provide evidence on the effectiveness of specialized, multidisciplinary, outpatient palliative care intervention (Advance Care Planning) in improving family satisfaction, symptom management and quality of life. PD_Pal will also further prove the feasibility and economic sustainability of this approach by the active involvement of patients lay associations as well relevant medical societies. PD_Pal team includes leading experts in both neurology and palliative care with key-roles in both national and international PD working groups. PD_Pal will develop a new set of evidence-based Guidelines and a Massive Online Course (MOOC) for Palliative Care in PD involving in the process experts from the European Association for Palliative Care, the European Academy of Neurology and the Movement Disorders Society. Thus, PD_Pal is best positioned to transfer this knowledge to all European countries and ensure that “PD_Pal Guidelines” will translate into best practice. The PD_Pal MOOC “Best Care for People with Late Stage Parkinson” will be integrated into the WHO supported interdisciplinary post-graduate palliative care curriculum.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PD_PAL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PD_PAL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

ENDOSCAPE (2019)

ENDOSCAPE, a clinically applicable non-viral gene delivery technology

Read More  

DIAdIC (2019)

Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial

Read More  

ESCALON (2019)

European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development

Read More